Champlain Investment Partners LLC decreased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 0.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 114,847 shares of the medical instruments supplier’s stock after selling 690 shares during the period. Champlain Investment Partners LLC’s holdings in Mettler-Toledo International were worth $172,236,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in MTD. Gateway Investment Advisers LLC purchased a new stake in shares of Mettler-Toledo International in the 2nd quarter worth $685,000. Swedbank AB bought a new position in Mettler-Toledo International during the 1st quarter worth about $26,867,000. SG Americas Securities LLC increased its position in Mettler-Toledo International by 52.9% during the 2nd quarter. SG Americas Securities LLC now owns 4,516 shares of the medical instruments supplier’s stock valued at $6,312,000 after purchasing an additional 1,562 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in shares of Mettler-Toledo International by 14.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock valued at $1,860,000 after purchasing an additional 152 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC lifted its position in shares of Mettler-Toledo International by 212.2% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock worth $1,828,000 after purchasing an additional 889 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.94% of the stock is currently owned by company insiders.
Mettler-Toledo International Stock Up 1.8 %
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The business had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on MTD shares. Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Robert W. Baird cut their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus lowered their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Mettler-Toledo International presently has an average rating of “Hold” and an average price target of $1,338.75.
Check Out Our Latest Research Report on MTD
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Articles
- Five stocks we like better than Mettler-Toledo International
- How to Choose Top Rated Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What is the S&P/TSX Index?
- MarketBeat Week in Review – 11/18 – 11/22
- The How And Why of Investing in Oil Stocks
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.